Who Buys Roxithromycin from India — 125 Importers Behind a $4.2M Market
India's roxithromycin import market is served by 125 active buyers who collectively imported $4.2M across 427 shipments. MILITARY COMMERICAL JOINT STOCK BANK (VIETNAM) leads with a 14.2% market share, followed by TEVA PHARMA (NEW ZEALAND) LIMITED and APOTEX PTY LTD.,. The top 5 buyers together control 32.2% of total import value, reflecting a moderately competitive buyer landscape.
Top Roxithromycin Importers — Ranked by Import Value
MILITARY COMMERICAL JOINT STOCK BANK (VIETNAM) is the leading roxithromycin importer from India, holding a 14.2% share of the $4.2M market across 427 shipments from 125 buyers. The top 5 buyers — MILITARY COMMERICAL JOINT STOCK BANK (VIETNAM), TEVA PHARMA (NEW ZEALAND) LIMITED (NEW ZEALAND), APOTEX PTY LTD., (AUSTRALIA), TEVA PHARMA NEW ZEALAND LIMITED (NEW ZEALAND), ISKP PHARMA CO., LTD (CAMBODIA) — collectively control 32.2% of total import value.
Top Roxithromycin Buyers & Importers
Ranked by import value · 125 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | MILITARY COMMERICAL JOINT STOCK BANKVIETNAM ROXITHROMYCIN TABLETS 150MG (WHITE CIRCUROXITHROMYCIN TABLETS 150MG. (BOX OF 10XROXITHROMYCIN 150 (ROXITHROMYCIN 150MG T | $590.8K | 5 | 14.2% |
| 2 | TEVA PHARMA (NEW ZEALAND) LIMITEDNEW ZEALAND PHARMACEUTICAL PRODUCTS - ROXITHROMYCIN300 MG TABLETSROXITHROMYCIN 150 MG TABLETS 12960 PACKROXITHROMYCIN 150 MG TABLETS (12030 PACK | $235.2K | 5 | 5.6% |
| 3 | APOTEX PTY LTD.,AUSTRALIA APX- ROXITHROMYCIN ROXITHROMYCIN TABLETSROXAR 150 ROXITHROMYCIN TABLETS 150MGROXAR 300 ROXITHROMYCIN TABLETS 300MG 66,075.00 X 1X5'SNOS | $182.5K | 5 | 4.4% |
| 4 | TEVA PHARMA NEW ZEALAND LIMITEDNEW ZEALAND PHARMACEUTICAL PRODUCTS - ROXITHROMYCIN300 MG TABLETSROXITHROMYCIN 150 MG TABLETS 12960 PACKROXITHROMYCIN 150 MG TABLETS (12030 PACK | $170.2K | 5 | 4.1% |
| 5 | ISKP PHARMA CO., LTDCAMBODIA PHARMA.PRODUCTS.-ROXITHROMYCIN TABLETS 1ROXYPAR-150 10X10A/A TAB ROXITHROMYCIN TARUROX :B/NO. | $164.8K | 5 | 3.9% |
| 6 | HEUMANN PHARMA GMBH CO. GENERICA KGGERMANY ROXITHROMYCIN 300 HEUMANN NOS SIZE 1 X 10 TABLETSROXITHROMYCIN 300 HEUMANNNOS SIZE 1X10 TABLETSROXITHROMYCIN 300 HEUMANN TABLET NOS SIZE 1X7 TABLETS | $159.7K | 5 | 3.8% |
| 7 | ARROW PHARMACEUTICALS PTY LTD,AUSTRALIA APX- ROXITHROMYCIN ROXITHROMYCIN TABLETSROXAR 150 ROXITHROMYCIN TABLETS 150MGROXAR 300 ROXITHROMYCIN TABLETS 300MG 66,075.00 X 1X5'SNOS | $150.2K | 5 | 3.6% |
| 8 | OPHAM - ROUTE DIGUE ANDRANOAMBOMADAGASCAR HARMLESS MEDICINE- ROXITHROMYCIN 150 MG | $129.0K | 5 | 3.1% |
| 9 | ARROW PHARMACEUTICALS PTY LTD.,AUSTRALIA APX- ROXITHROMYCIN ROXITHROMYCIN TABLETSROXAR 150 ROXITHROMYCIN TABLETS 150MGROXAR 300 ROXITHROMYCIN TABLETS 300MG 66,075.00 X 1X5'SNOS | $112.2K | 5 | 2.7% |
| 10 | CAMEL INTERNATIONAL IM-EXPORTVIETNAM ROXITHROMYCIN TABLETS 150MG (WHITE CIRCUROXITHROMYCIN TABLETS 150MG. (BOX OF 10XROXITHROMYCIN 150 (ROXITHROMYCIN 150MG T | $93.2K | 5 | 2.2% |
| 11 | NUTRI-PHARMA USA COMPANY LIMITEDVIETNAM ROXITHROMYCIN TABLETS 150MG (WHITE CIRCUROXITHROMYCIN TABLETS 150MG. (BOX OF 10XROXITHROMYCIN 150 (ROXITHROMYCIN 150MG T | $83.1K | 5 | 2.0% |
| 12 | APOTEX PTY LIMITEDAUSTRALIA APX- ROXITHROMYCIN ROXITHROMYCIN TABLETSROXAR 150 ROXITHROMYCIN TABLETS 150MGROXAR 300 ROXITHROMYCIN TABLETS 300MG 66,075.00 X 1X5'SNOS | $77.0K | 5 | 1.8% |
| 13 | APOTEX PTY LTDAUSTRALIA APX- ROXITHROMYCIN ROXITHROMYCIN TABLETSROXAR 150 ROXITHROMYCIN TABLETS 150MGROXAR 300 ROXITHROMYCIN TABLETS 300MG 66,075.00 X 1X5'SNOS | $69.4K | 5 | 1.7% |
| 14 | ARROW PHARMACEUTICALS PTY LTDAUSTRALIA APX- ROXITHROMYCIN ROXITHROMYCIN TABLETSROXAR 150 ROXITHROMYCIN TABLETS 150MGROXAR 300 ROXITHROMYCIN TABLETS 300MG 66,075.00 X 1X5'SNOS | $55.4K | 5 | 1.3% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Roxithromycin — and from which countries?
Flow of Roxithromycin exports from India: each country's share and the named importers behind the numbers
Roxithromycin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Vietnam
Vietnam emerges as the first largest importing country, achieving a total trade value of $1.4M through 10 shipments. This represents a market share of 33.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Vietnam has a diverse importer base, with their top importers including:
• MILITARY COMMERICAL JOINT STOCK BANK - $590.8K (41.8% of country's total business)
• CAMEL INTERNATIONAL IM-EXPORT - $93.2K (6.6% of country's total business)
• NUTRI-PHARMA USA COMPANY LIMITED - $83.1K (5.9% of country's total business)
Key Insight: Vietnam demonstrates strong market positioning with an average shipment value of $141.3K, indicating premium pricing strategy compared to the market average of $9.8K.
Vietnam is a key market for Roxithromycin imports, representing 33.9% of total trade value.
2Cambodia
Cambodia emerges as the second largest importing country, achieving a total trade value of $763.2K through 4 shipments. This represents a market share of 18.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Cambodia has a diverse importer base, with their top importers including:
• ISKP PHARMA CO., LTD - $164.8K (21.6% of country's total business)
Key Insight: Cambodia demonstrates strong market positioning with an average shipment value of $190.8K, indicating premium pricing strategy compared to the market average of $9.8K.
Cambodia is a key market for Roxithromycin imports, representing 18.3% of total trade value.
3Australia
Australia emerges as the third largest importing country, achieving a total trade value of $758.8K through 45 shipments. This represents a market share of 18.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• APOTEX PTY LTD., - $182.5K (24.1% of country's total business)
• ARROW PHARMACEUTICALS PTY LTD, - $150.2K (19.8% of country's total business)
• ARROW PHARMACEUTICALS PTY LTD., - $112.2K (14.8% of country's total business)
• APOTEX PTY LIMITED - $77.0K (10.1% of country's total business)
• APOTEX PTY LTD - $69.4K (9.1% of country's total business)
• Rest of Australia's importers - $167.4K (22.1% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $16.9K, indicating premium pricing strategy compared to the market average of $9.8K.
Australia is a key market for Roxithromycin imports, representing 18.2% of total trade value.
4New Zealand
New Zealand emerges as the fourth largest importing country, achieving a total trade value of $405.4K through 10 shipments. This represents a market share of 9.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: New Zealand has a diverse importer base, with their top importers including:
• TEVA PHARMA (NEW ZEALAND) LIMITED - $235.2K (58.0% of country's total business)
• TEVA PHARMA NEW ZEALAND LIMITED - $170.2K (42.0% of country's total business)
Key Insight: New Zealand demonstrates strong market positioning with an average shipment value of $40.5K, indicating premium pricing strategy compared to the market average of $9.8K.
New Zealand is a key market for Roxithromycin imports, representing 9.7% of total trade value.
5Myanmar
Myanmar emerges as the fifth largest importing country, achieving a total trade value of $233.2K through 0 shipments. This represents a market share of 5.6% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Myanmar demonstrates strong market positioning with an average shipment value of $233.2K, indicating premium pricing strategy compared to the market average of $9.8K.
Myanmar is a key market for Roxithromycin imports, representing 5.6% of total trade value.
Buyer Segment Analysis
TransData Nexus Roxithromycin buyer market intelligence
1Buyer Segment Analysis
Our data indicates that Roxithromycin exports from India amounted to $4.2 million across 427 shipments, involving 78 exporters and reaching 30 importing countries. Among the 125 buyers, the repeat buyer rate stands at 51.2%, suggesting a stable demand from established customers.
Distributors: Entities such as TEVA PHARMA (NEW ZEALAND) LIMITED and APOTEX PTY LTD. in Australia likely function as distributors. These companies typically procure large quantities to supply regional markets, maintaining consistent order patterns to ensure a steady supply chain.
Hospital Groups: While specific hospital groups are not explicitly listed among the top buyers, it's common for large healthcare institutions to import pharmaceuticals directly. Their purchasing behavior often involves bulk orders aligned with patient treatment needs and formulary requirements.
Retail Chains: Retail pharmacy chains may also be among the buyers, sourcing Roxithromycin to meet consumer demand. Their orders are generally smaller and more frequent, reflecting retail sales patterns and inventory turnover rates.
Government Procurement: Entities like MILITARY COMMERCIAL JOINT STOCK BANK in Vietnam may represent government procurement channels. Such buyers often engage in tender-based purchasing, securing large volumes to supply public healthcare facilities, with order patterns influenced by budget cycles and public health initiatives.
Re-exporters: Companies such as CAMEL INTERNATIONAL IM-EXPORT in Vietnam might act as re-exporters, importing Roxithromycin for distribution to neighboring markets. Their buying behavior is characterized by variable order sizes, depending on regional demand fluctuations.
Contract Manufacturers: Some buyers may be contract manufacturers who import Roxithromycin as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement is typically project-based, with orders corresponding to production schedules and client contracts.
Country-Specific Import Regulations
TransData Nexus Roxithromycin buyer market intelligence
1Country-Specific Import Regulations
Vietnam:
1. Drug Regulatory Authority: Drug Administration of Vietnam (DAV) under the Ministry of Health.
2. Import Registration Process: Importers must obtain a drug import license from the DAV. The process involves submitting an application with required documents, including the Certificate of Pharmaceutical Product (CPP) and Good Manufacturing Practice (GMP) certificates.
3. Estimated Timeline for Registration: The DAV has streamlined procedures, processing over 1,700 drug import license applications in 2025, with an average processing time of approximately 114.5 days. (vietnam.vn)
4. Import Tariff/Duty for HS 30049099: Under the ASEAN-India Free Trade Agreement (AIFTA), the import duty for pharmaceuticals classified under HS code 30049099 is 0%.
Cambodia:
1. Drug Regulatory Authority: Department of Drugs and Food (DDF) under the Ministry of Health.
2. Import Registration Process: Importers must register with the DDF and obtain an import license. The process includes submitting a customs import declaration, commercial invoice, packing list, bill of lading, import permit, insurance certificate, tax certificate, certificate of origin, and company registration. (khmersme.gov.kh)
3. Estimated Timeline for Registration: Specific timelines are not provided in the available sources.
4. Import Tariff/Duty for HS 30049099: Cambodia applies import duties ranging from 0% to 35%, with pharmaceuticals generally subject to lower rates. Additionally, a 10% value-added tax (VAT) is levied on all imported goods. (khmersme.gov.kh)
Australia:
1. Drug Regulatory Authority: Therapeutic Goods Administration (TGA) under the Department of Health.
2. Import Registration Process: Importers must register the pharmaceutical product with the TGA, providing comprehensive data on quality, safety, and efficacy. The process includes submitting an application in the Common Technical Document (CTD) format.
3. Estimated Timeline for Registration: The TGA aims to complete evaluations within 255 working days for standard applications.
4. Import Tariff/Duty for HS 30049099: Australia generally applies a 5% import duty on pharmaceuticals under HS code 30049099, with certain exemptions under free trade agreements.
New Zealand:
1. Drug Regulatory Authority: Medsafe under the Ministry of Health.
2. Import Registration Process: Importers must submit a New Medicine Application (NMA) to Medsafe, including data on quality, safety, and efficacy. The process involves a comprehensive evaluation of the submitted dossier.
3. Estimated Timeline for Registration: Medsafe aims to complete the evaluation of NMAs within 200 working days.
4. Import Tariff/Duty for HS 30049099: New Zealand applies a 0% import duty on pharmaceuticals under HS code 30049099.
Myanmar:
1. Drug Regulatory Authority: Food and Drug Administration (FDA) under the Ministry of Health.
2. Import Registration Process: Importers must register the pharmaceutical product with the FDA Myanmar, submitting a dossier in the ASEAN Common Technical Dossier (ACTD) format. The process includes obtaining a Drug Importation Approval Certificate (DIAC).
3. Estimated Timeline for Registration: Specific timelines are not provided in the available sources.
4. Import Tariff/Duty for HS 30049099: Myanmar's import tariffs range from 0% to 40%, with pharmaceuticals typically taxed at lower rates. Additionally, a commercial tax of 5% to 25% is levied, depending on the product category. (mofa.gov.mm)
Demand Drivers & Market Opportunity
TransData Nexus Roxithromycin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Roxithromycin in importing countries is primarily driven by the prevalence of bacterial infections, particularly respiratory tract infections, for which Roxithromycin is commonly prescribed. Government healthcare programs and the expansion of universal health coverage in countries like Vietnam and Cambodia have increased access to essential medicines, thereby boosting demand. Additionally, the inclusion of Roxithromycin in the World Health Organization's Essential Medicines List facilitates its procurement through international and national tender-based purchasing systems.
Our data, encompassing 125 buyers across 30 countries, indicates a diverse and stable market for Roxithromycin. The repeat buyer rate of 51.2% suggests sustained demand, while the presence of multiple importing countries highlights the global reliance on Indian pharmaceutical exports to meet healthcare needs.
Common Questions — Roxithromycin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest roxithromycin buyer importing from India?
Based on import volume and value, MILITARY COMMERICAL JOINT STOCK BANK (VIETNAM) leads with $590.8K in imports and a 14.2% market share — the highest of any single roxithromycin importer. TEVA PHARMA (NEW ZEALAND) LIMITED (NEW ZEALAND) and APOTEX PTY LTD., (AUSTRALIA) are the next largest buyers.
QHow many companies buy roxithromycin from India?
There are 125 active roxithromycin buyers importing from India, with a combined market of $4.2M across 427 shipments to 30 countries. The top 5 buyers hold 32.2% of total import value, while the remaining 120 buyers handle the other 67.8%.
QWhich countries import the most roxithromycin from India?
The top importing countries for roxithromycin from India are Vietnam (33.9%), Cambodia (18.3%), Australia (18.2%), New Zealand (9.7%), Myanmar (5.6%). These markets represent the largest demand centres for Indian pharmaceutical exports of roxithromycin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for roxithromycin from India?
The average import transaction value for roxithromycin from India is $9.8K, with an average unit price of $14.67 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Roxithromycin buyer market intelligence
1Buyer Segment Analysis
Our data indicates that Roxithromycin exports from India amounted to $4.2 million across 427 shipments, involving 78 exporters and reaching 30 importing countries. Among the 125 buyers, the repeat buyer rate stands at 51.2%, suggesting a stable demand from established customers.
Distributors: Entities such as TEVA PHARMA (NEW ZEALAND) LIMITED and APOTEX PTY LTD. in Australia likely function as distributors. These companies typically procure large quantities to supply regional markets, maintaining consistent order patterns to ensure a steady supply chain.
Hospital Groups: While specific hospital groups are not explicitly listed among the top buyers, it's common for large healthcare institutions to import pharmaceuticals directly. Their purchasing behavior often involves bulk orders aligned with patient treatment needs and formulary requirements.
Retail Chains: Retail pharmacy chains may also be among the buyers, sourcing Roxithromycin to meet consumer demand. Their orders are generally smaller and more frequent, reflecting retail sales patterns and inventory turnover rates.
Government Procurement: Entities like MILITARY COMMERCIAL JOINT STOCK BANK in Vietnam may represent government procurement channels. Such buyers often engage in tender-based purchasing, securing large volumes to supply public healthcare facilities, with order patterns influenced by budget cycles and public health initiatives.
Re-exporters: Companies such as CAMEL INTERNATIONAL IM-EXPORT in Vietnam might act as re-exporters, importing Roxithromycin for distribution to neighboring markets. Their buying behavior is characterized by variable order sizes, depending on regional demand fluctuations.
Contract Manufacturers: Some buyers may be contract manufacturers who import Roxithromycin as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement is typically project-based, with orders corresponding to production schedules and client contracts.
Country-Specific Import Regulations
TransData Nexus Roxithromycin buyer market intelligence
1Country-Specific Import Regulations
Vietnam:
1. Drug Regulatory Authority: Drug Administration of Vietnam (DAV) under the Ministry of Health.
2. Import Registration Process: Importers must obtain a drug import license from the DAV. The process involves submitting an application with required documents, including the Certificate of Pharmaceutical Product (CPP) and Good Manufacturing Practice (GMP) certificates.
3. Estimated Timeline for Registration: The DAV has streamlined procedures, processing over 1,700 drug import license applications in 2025, with an average processing time of approximately 114.5 days. (vietnam.vn)
4. Import Tariff/Duty for HS 30049099: Under the ASEAN-India Free Trade Agreement (AIFTA), the import duty for pharmaceuticals classified under HS code 30049099 is 0%.
Cambodia:
1. Drug Regulatory Authority: Department of Drugs and Food (DDF) under the Ministry of Health.
2. Import Registration Process: Importers must register with the DDF and obtain an import license. The process includes submitting a customs import declaration, commercial invoice, packing list, bill of lading, import permit, insurance certificate, tax certificate, certificate of origin, and company registration. (khmersme.gov.kh)
3. Estimated Timeline for Registration: Specific timelines are not provided in the available sources.
4. Import Tariff/Duty for HS 30049099: Cambodia applies import duties ranging from 0% to 35%, with pharmaceuticals generally subject to lower rates. Additionally, a 10% value-added tax (VAT) is levied on all imported goods. (khmersme.gov.kh)
Australia:
1. Drug Regulatory Authority: Therapeutic Goods Administration (TGA) under the Department of Health.
2. Import Registration Process: Importers must register the pharmaceutical product with the TGA, providing comprehensive data on quality, safety, and efficacy. The process includes submitting an application in the Common Technical Document (CTD) format.
3. Estimated Timeline for Registration: The TGA aims to complete evaluations within 255 working days for standard applications.
4. Import Tariff/Duty for HS 30049099: Australia generally applies a 5% import duty on pharmaceuticals under HS code 30049099, with certain exemptions under free trade agreements.
New Zealand:
1. Drug Regulatory Authority: Medsafe under the Ministry of Health.
2. Import Registration Process: Importers must submit a New Medicine Application (NMA) to Medsafe, including data on quality, safety, and efficacy. The process involves a comprehensive evaluation of the submitted dossier.
3. Estimated Timeline for Registration: Medsafe aims to complete the evaluation of NMAs within 200 working days.
4. Import Tariff/Duty for HS 30049099: New Zealand applies a 0% import duty on pharmaceuticals under HS code 30049099.
Myanmar:
1. Drug Regulatory Authority: Food and Drug Administration (FDA) under the Ministry of Health.
2. Import Registration Process: Importers must register the pharmaceutical product with the FDA Myanmar, submitting a dossier in the ASEAN Common Technical Dossier (ACTD) format. The process includes obtaining a Drug Importation Approval Certificate (DIAC).
3. Estimated Timeline for Registration: Specific timelines are not provided in the available sources.
4. Import Tariff/Duty for HS 30049099: Myanmar's import tariffs range from 0% to 40%, with pharmaceuticals typically taxed at lower rates. Additionally, a commercial tax of 5% to 25% is levied, depending on the product category. (mofa.gov.mm)
Demand Drivers & Market Opportunity
TransData Nexus Roxithromycin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Roxithromycin in importing countries is primarily driven by the prevalence of bacterial infections, particularly respiratory tract infections, for which Roxithromycin is commonly prescribed. Government healthcare programs and the expansion of universal health coverage in countries like Vietnam and Cambodia have increased access to essential medicines, thereby boosting demand. Additionally, the inclusion of Roxithromycin in the World Health Organization's Essential Medicines List facilitates its procurement through international and national tender-based purchasing systems.
Our data, encompassing 125 buyers across 30 countries, indicates a diverse and stable market for Roxithromycin. The repeat buyer rate of 51.2% suggests sustained demand, while the presence of multiple importing countries highlights the global reliance on Indian pharmaceutical exports to meet healthcare needs.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 125 global importers of Roxithromycin identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 427 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 30 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
427 Verified Shipments
125 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists